Medicaid Rx Drugs Shifting Away from FFS

U.S health care policymakers just announced their plans to expand the Home Health Value-Based Purchasing (HHVBP) Model.


January 18, 2021 – The Centers for Medicare & Medicaid Services (CMS) has spent 4 years advancing value-based care across all programs. They also sought to remove barriers to value-based payments for drug pricing. The CMS released a new rule, “Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements,” ushers in a new era of value-based drug reimbursement. This rule removes regulatory barriers for Medicaid drug reimbursement.

Click here to read the full report from the Centers for Medicare & Medicaid Services.

The VBP Blog is a comprehensive resource for all things related to value-based payments. We provide up to date news, informative webinars, and relevant blogs in the VBP sphere to help your organization find success. 

Get even more VBP insights on LinkedIn & Twitter

Subscribe here to receive the blogs straight to your inbox

More Trending Topics:

two laptop computers

CMS Extends Open Enrollment Period

Beginning this year, consumers will have an extra 30 days to review and choose health plans through Open Enrollment, which will run from November 1, 2021, through January 15, 2022, on HealthCare.gov

Read More »